Financhill
Back

Livento Group, Inc. Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison

Sell
41

NUGN
Livento Group, Inc.

Last Price:
$0.0000
Seasonality Move:
0.6%
Buy
61

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$117.57
Seasonality Move:
-9.01%
Sell
41
Livento Group, Inc. (NUGN) is a Sell

Is Livento Group, Inc. a Buy, Sell or Hold?

  • The current Livento Group, Inc. [NUGN] share price is $0.0029. The Score for NUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.77. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NUGN Stock Price Chart

What is Livento Group, Inc.'s stock price today?

  • The Livento Group, Inc. share price today is $0.0029
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $104.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

NUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: 370356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0023 - 0.0023) Buy
Bollinger Bands (100): (0.0031 - 0.0031) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 51.18 Buy
Chaikin Money Flow: 492572 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Buy
20-day SMA: 0 Buy
50-day SMA: 0 Buy
200-day SMA: 8.31 Sell
8-day EMA: 0 Buy
20-day EMA: 0 Buy
50-day EMA: 0.11 Sell
200-day EMA: 24.29 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104 Buy
20-day SMA: 103.19 Buy
50-day SMA: 104.46 Buy
200-day SMA: 81.11 Buy
8-day EMA: 104.12 Buy
20-day EMA: 104.09 Buy
50-day EMA: 102.96 Buy
200-day EMA: 86.07 Buy

Livento Group, Inc. Earnings Growth & NUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Livento Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):